Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 8/2018

01-08-2018 | Original Communication

Comparison of CT black hole sign and other CT features in predicting hematoma expansion in patients with ICH

Authors: Gui-Nv He, Hao-Zhan Guo, Xiong Han, En-Feng Wang, Yan-Qiu Zhang

Published in: Journal of Neurology | Issue 8/2018

Login to get access

Abstract

Background and purpose

The hematoma expansion (HE) is an important risk factor for early neurological deterioration and poor prognosis. In this study, we aimed to compare the black hole sign with other computed tomography (CT) features to predict the HE and the outcome in patients with intracerebral hemorrhage (ICH).

Methods

Patients were enrolled within 12 h after stroke attack in the emergency department of Henan Provincial People’s Hospital between January 2012 and June 2016. The clinical characters and CT features including the initial CT and the follow-up CT within 48 h were recorded. The outcome was assessed by using the modified Rankin Scale on discharge. Logistic regression analyses were used to investigate whether the factors were the independent predictor of HE and the outcome in patients with ICH. The sensitivity, specificity, positive predictive value, and negative predictive of CT features in predicting HE were calculated.

Results

A total of 185 ICH patients were enrolled, including 70 (37.8%) patients in HE group and 115 (62.2%) patients in non-HE group. There were significant difference in the initial hematoma volume, irregular shape, and CT black hole sign (P = 0.013, 0.006 and P < 0.001) between the two groups. While irregular shape and CT black hole sign were independent predictors for HE, the sensitivity and specificity were 71.45 and 54.78, 51.4 and 81.7%, respectively. Multivariable analysis identified CT black hole sign (P = 0.108) and initial intraventricular hemorrhage expansion (P = 0.214) were not the independent predictors of poor outcome.

Conclusion

CT black hole sign presented the best predictive accuracy of predicting HE in patients with ICH compared to other CT features. However, it was not an independent predictor of poor outcome.
Literature
1.
2.
Fan JS, Huang HH, Chen YC, Yen DH, Kao WF, Huang MS et al (2012) Emergency department neurologic deterioration in patients with spontaneous intracerebral hemorrhage: incidence, predictors, and prognostic significance. Acad Emerg Med 19(2):133–138CrossRefPubMed
3.
Rodriguez-Luna D, Pineiro S, Rubiera M, Ribo M, Coscojuela P, Pagola J et al (2013) Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage. Eur J Neurol 20(9):1277–1283CrossRefPubMed
4.
Ovesen C, Christensen AF, Havsteen I, Krarup Hansen C, Rosenbaum S, Kurt E et al (2015) Prediction and prognostication of neurological deterioration in patients with acute ICH: a hospital-based cohort study. BMJ Open 5:e008563CrossRefPubMedPubMedCentral
5.
Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, The Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators et al (2006) Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 66(8):1175–1181CrossRefPubMed
6.
Delcourt C, Huang Y, Arima H, Chalmers J, Davis SM, Heeley EL et al (2012) Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study. Neurology 79(4):314–319CrossRefPubMed
7.
Brouwers HB, Goldstein JN, Romero JM, Rosand J (2012) Clinical applications of the CT angiography spot sign in acute intracerebral hemorrhage: a review. Stroke 43(12):3427–3432CrossRefPubMedPubMedCentral
8.
Demchuk AM, Dowlatshahi D, Rodriguez-Luna D, Molina CA, Blas YS, Dzialowski I, PREDICT/Sunnybrook ICH CTA Study Group et al (2012) Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol 11:307–314CrossRefPubMed
9.
Peng WJ, Reis C, Reis H, Zhang J, Yang J (2017) Predictive value of CTA spot sign on hematoma expansion in intracerebral hemorrhage patients. Biomed Res Int 2017:4137210PubMedPubMedCentral
10.
Hemphill JC, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M et al (2015) Guidelines for the management of spontaneous intracerebral hemorrhage a guideline for healthcare professionals from the American heart association/American stroke association. Stroke 46(7):2032–2060CrossRefPubMed
11.
Boulouis G, Morotti A, Charidimou A, Dowlatshahi D, Goldstein JN (2017) Noncontrast computed tomography markers of intracerebral hemorrhage expansion. Stroke 48(4):1120–1125CrossRefPubMedPubMedCentral
12.
Sporns PB, Schwake M, Kemmling A, Minnerup J, Schwindt W, Niederstadt T et al (2017) Comparison of spot sign, blend sign and black hole sign for outcome prediction in patients with intracerebral hemorrhage. J Stroke 19(3):333–339CrossRefPubMedPubMedCentral
13.
Li Q, Zhang G, Xiong X, Wang XC, Yang WS, Li KW et al (2016) Black hole sign novel imaging marker that predicts hematoma growth in patients with intracerebral hemorrhage. Stroke 47(7):1777–1781CrossRefPubMed
14.
Li Q, Huang YJ, Zhang G, Lv FJ, Wei X, Dong MX et al (2015) Intraventricular hemorrhage and early hematoma expansion in patients with intracerebral hemorrhage. Sci Rep 5:11357CrossRefPubMedPubMedCentral
15.
Boulouis G, Morotti A, Brouwers HB, Charidimou A, Jessel MJ, Auriel E et al (2016) Association between hypodensities detected by computed tomography and hematoma expansion in patients with intracerebral hemorrhage. JAMA Neurol 73(8):961–968CrossRefPubMedPubMedCentral
16.
Li Q, Zhang G, Huang YJ, Dong MX, Lv FJ, Wei X et al (2015) Blend sign on computed tomography novel and reliable predictor for early hematoma growth in patients with intracerebral hemorrhage. Stroke 46(8):2119–2123CrossRefPubMed
17.
Li Q, Liu QJ, Yang WS, Wang XC, Zhao LB et al (2017) Island sign an imaging predictor for early hematoma expansion and poor outcome in patients with intracerebral hemorrhage. Stroke 48(11):3019–3025CrossRefPubMed
18.
Yu Z, Zheng J, Ali H, Guo R, Li M, Wang X et al (2017) Significance of satellite sign and spot sign in predicting hematoma expansion in spontaneous intracerebral hemorrhage. Clin Neurol Neurosurg 162:67–71CrossRefPubMed
19.
Morotti A, Boulouis G, Romero JM, Brouwers HB, Jessel MJ, Vashkevich A et al (2017) Blood pressure reduction and noncontrast CT markers of intracerebral hemorrhage expansion. Neurology 89(6):548–554CrossRefPubMedPubMedCentral
20.
Xiong X, Li Q, Yang WS, Wei X, Hu X, Wang XC et al (2018) Comparison of swirl sign and black hole sign in predicting early hematoma growth in patients with spontaneous intracerebral hemorrhage. Med Sci Monit 24:567–573CrossRefPubMedPubMedCentral
21.
22.
Yu Z, Zheng J, Ma L, Guo R, Li M, Wang X et al (2017) The predictive accuracy of the black hole sign and the spot sign for hematoma expansion in patients with spontaneous intracerebral hemorrhage. Neurol Sci 38(9):1951–1957CrossRef
23.
Schlunk F, Greenberg SM (2015) The pathophysiology of intracerebral hemorrhage formation and expansion. Transl Stroke Res 6(4):257–263CrossRefPubMed
24.
Blacquiere D, Demchuk AM, Al-Hazzaa M, Deshpande A, Petrcich W, Aviv RI, PREDICT/Sunnybrook ICH CTA Study Group et al (2015) Intracerebral hematoma morphologic appearance on noncontrast computed tomography predicts significant hematoma expansion. Stroke 46(11):3111–3116CrossRefPubMed
25.
Barras CD, Tress BM, Christensen S, MacGregor L, Collins M, Desmond PM et al (2009) Density and shape as CT predictors of intracerebral hemorrhage growth. Stroke 40(4):1325–1331CrossRefPubMed
26.
Sorimachi T, Fujii Y (2010) Early neurological change in patients with spontaneous supratentorial intracerebral hemorrhage. J Clin Neurosci 17(11):1367–1371CrossRefPubMed
27.
Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T (1997) Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 28(12):2370–2375CrossRefPubMed
28.
Kazui S, Minematsu K, Yamamoti H, Sawada T, Yamaguchi T (1997) Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 28(12):2370–2375CrossRefPubMed
29.
Takeda R, Ogura T, Ooigawa H, Fushihara G, Yoshikawa S, Okada D et al (2013) A practical prediction model for early hematoma expansion in spontaneous deep ganglionic intracerebral hemorrhage. Clin Neurol Neurosurg 115(7):1028–1031CrossRefPubMed
30.
Broderick JP, Diringer MN, Hill MD, Brun NC, Mayer SA, Steiner T et al (2007) Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke 38(3):1072–1075CrossRefPubMed
31.
Park SY, Kong MH, Kim JH, Kang DS, Song KY, Huh SK (2010) Role of ‘Spot Sign’on CT angiography to predict hematoma expansion in spontaneous intracerebral hemorrhage. J Korean Neurosurg Soc 48(5):399–405CrossRefPubMedPubMedCentral
32.
Dowlatshahi D, Smith EE, Flaherty ML, Ali M, Lyden P, Demchuk AM, VISTA Collaborators (2011) Small intracerebral haemorrhages are associated with less haematoma expansion and better outcomes. Int J Stroke 6(3):201–206CrossRefPubMed
33.
Bhattathiri PS, Gregson B, Prasad KS, Mendelow AD, STICH Investigators (2006) Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial. Acta Neurochir Suppl (Wien) 96:65–68CrossRef
34.
Steiner T, Diringer MN, Schneider D, Mayer SA, Begtrup K, Broderick J et al (2006) Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery 59(4):767–773CrossRefPubMed
35.
Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R (1998) Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 29(6):1160–1166CrossRefPubMed
36.
Li Q, Yang WS, Chen SL, Lv FR, Lv FJ, Hu X et al (2018) Black hole sign predicts poor outcome in patients with intracerebral hemorrhage. Cerebrovasc Dis 45(1–2):48–53CrossRefPubMed
37.
Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN et al (2005) Recombinant activated factor VII intracerebral hemorrhage trial investigators: recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352:777–785CrossRefPubMed
38.
Moullaali TJ, Sato S, Wang X, Rabinstein AA, Arima H, Carcel C et al (2017) Prognostic significance of delayed intraventricular haemorrhage in the INTERACT studies. J Neurol Neurosurg Psychiatry 88(1):1–6CrossRef
39.
Delcourt C, Zhang S, Arima H, Sato S, Al-Shahi Salman R, Wang X et al (2016) Significance of hematoma shape and density in intracerebral hemorrhage: the intensive blood pressure reduction in acute intracerebral hemorrhagetrial study. Stroke 47(5):1227–1232CrossRefPubMed
40.
Witsch J, Bruce E, Meyers E, Velazquez A, Schmidt JM, Suwatcharangkoon S et al (2015) Intraventricular hemorrhage expansion in patients with spontaneous intracerebral hemorrhage. Neurology 84(10):989–994CrossRefPubMedPubMedCentral
Metadata
Title
Comparison of CT black hole sign and other CT features in predicting hematoma expansion in patients with ICH
Authors
Gui-Nv He
Hao-Zhan Guo
Xiong Han
En-Feng Wang
Yan-Qiu Zhang
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 8/2018
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-018-8932-6

Other articles of this Issue 8/2018

Journal of Neurology 8/2018 Go to the issue

Original Communication

Detection of JC virus archetype in cerebrospinal fluid in a MS patient with dimethylfumarate treatment without lymphopenia or signs of PML

Original Communication

Depressive symptoms in stroke patients treated and non-treated with intravenous thrombolytic therapy: a 1-year follow-up study

Original Communication

Sarcoidosis of the central nervous system: clinical features, imaging, and CSF results

Original Communication

Primary lateral sclerosis and the amyotrophic lateral sclerosis–frontotemporal dementia spectrum

Review

Up-to-date knowledge about the association between multiple sclerosis and the reactivation of human endogenous retrovirus infections

Original Communication

Application value of serum biomarkers for choosing memantine therapy for moderate AD